Q-VANT Biosciences and SPI Pharma Launch QS-21 GH to Expand Global Access to Advanced Vaccine Adjuvants News Q-VANT Biosciences and SPI Pharma Launch QS-21 GH to Expand Global Access to Advanced Vaccine Adjuvants
